Everest Medicines announced the appointment of Kevin Guo as Chief Commercial Officer. Mr. Guo brings more than 22 years of commercial leadership and business management experience across a number of multinational pharmaceutical companies. Mr. Guo joins Everest Medicines after holding leadership positions at Eisai, where he most recently served as vice president and deputy global brand lead for LENVIMA, driving the development and execution of global product launch strategies, including in markets such as China, Japan and other Asia regions. Prior to this, he was vice president and head of the pharmaceutical business division of Eisai China Inc., where he managed several key business functions and was also appointed as chairman of the Board and president of Eisai (Suzhou) Trading Co. Ltd.